Merck Investing $49M In Asian Manufacturing and Distribution

07/02/2019

Merck Investing $49M In Asian Manufacturing and Distribution

 12-1-(2).jpg
 
          Merck is planning an additional investment of $49.3 million to strengthen its manufacturing and distribution platform in Asia over the next two years. This latest cash input follows the November 2016 announcement of its $98.6 million Life Science investment in Nantong, China.

          Udit Batra, a Merck Executive Board Member and CEO of the Life Science business sector remarked, “In biopharmaceutical research, time is of the essence.  Our investments in the important Asian markets of South Korea, India and China ensure that our customers have ready access to the products needed to develop new therapies and biosimilars that accelerate access to health for people everywhere.”
 

Page view : 24